The influence of sulindac and dacarbazine on their ability to initiate the process of apoptosis in malignant melanoma cells was measured by the content of p53, Bcl-2, and Bax proteins in the presence of the drugs in various concentrations. The gene discussed is BCL2; the disease is melanoma.